nusinersen studies continue to show efficacy and safety
Published 5 years ago • 69 plays • Length 4:46Download video MP4
Download video MP3
Similar videos
-
4:31
nusinersen: impact across the spectrum of sma
-
4:16
nusinersen clinical trial data
-
3:10
nusinersen treatment for older patients with sma
-
2:35
nusinersen treatment outcomes in later onset sma
-
24:01
the development journey of spinraza® (nusinersen): from advocacy to treatment and beyond
-
4:21
new clinical data on pediatric nusinersen treated patients with sma
-
4:18
nusinersen treated type 1 patients older than 7 months
-
4:02
clinical trials show continued improvement with risdiplam
-
4:39
nurture and shine long term safety and durability data
-
2:52
impact of nusinersen on respiratory and bulbar function
-
32:18
updates in spinal muscular atrophy
-
3:09
nusinersen endear-shine and cherish-shine for sma
-
3:14
nurture: nusinersen in presymptomatic patients
-
4:27
approval of nusinersen for sma
-
32:14
nusinersen (spinrazatm): the first fda approved treatment for sma
-
9:02
nusinersen: the first approval for spinal muscular atrophy
-
4:35
spinraza (nusinersen) approval
-
4:09
nusinersen for treatment of sma
-
6:05
nusinersen in adults with 5q sma